Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

9
Number of overlapping holdings
14.5%
% of HELX's 70 holdings also in PBE
32.1%
% of PBE's 28 holdings also in HELX
Overlap by Weight
Sector Drift (HELX minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in HELX |
Weight in PBE |
Overlap | |
---|---|---|---|---|
NATERA INC | 6.1% | 5.0% | 5.0% | |
REGENERON PHARMACEUTICALS | 3.6% | 4.7% | 3.6% | |
UNITED THERAPEUTICS CORP | 3.6% | 5.0% | 3.6% | |
SAREPTA THERAPEUTICS INC | 2.3% | 2.6% | 2.3% | |
EXACT SCIENCES CORP | 1.8% | 2.5% | 1.8% |
Position Highlights (Non-Overlapping Exposures)
HELX Overweight Relative to PBE
VERTEX PHARMACEUTICALS INC | 4.3% | |
KRYSTAL BIOTECH, INC. | 3.9% | |
MEDPACE HOLDINGS, INC. | 3.5% | |
SAMSUNG BIOLOGICS CO., LTD. | 3.3% | |
THERMO FISHER SCIENTIFIC INC | 3.2% | |
ELI LILLY & CO | 3.2% | |
BIONTECH SE SPONSORED ADR | 3.0% | |
ASTRAZENECA PLC-SPONS ADR | 2.7% | |
CORTEVA INC | 2.6% | |
INSMED INC | 2.4% |
HELX Underweight Relative to PBE
GILEAD SCIENCES INC | -6.2% | |
AMGEN INC | -5.2% | |
INCYTE CORP | -5.0% | |
BIOGEN IDEC INC | -4.5% | |
AXSOME THERAPEUTICS, INC. | -3.9% | |
BIOCRYST PHARMACEUTICALS INC | -3.5% | |
ROYALTY PHARMA PLC CLASS A | -3.5% | |
HALOZYME THERAPEUTICS INC | -3.3% | |
ACADIA PHARMACEUTICALS INC | -3.3% | |
ILLUMINA INC | -3.3% |